Amavita Foundation Introduces Miami Initiative to Stop Amputation Initiative to Support Cardiovascular Care in Miami-Dade County The initiative seeks to lower the number of non-traumatic lower extremity amputations because of peripheral artery disease (PAD) with early detection screenings. The Amavita Foundation, the nonprofit arm of Amavita Heart and Vascular Health, announced the launch of its
The Amavita Foundation, the nonprofit arm of Amavita Heart and Vascular Health (Amavita) has announced the launch of its inaugural initiative, the Miami Initiative to Stop Amputation (MISA). With a mission to tackle the rising rates of amputations due to peripheral artery disease (PAD), MISA aims to educate and empower both patients and healthcare providers
Gloria's Gab LIVE with Host Gloria Burns and guest, Dr. Pedro Martinez Clark of Amavita Heart & Vascular Health For more news, be sure to go to https://www.communitynewspapers.com #inspirehealth #hearthealthmonth #heartmonth #realestate #miamirealestate #miamicommunitynews #communitynewspapers ABOUT US: For more Miami community news, look no further than Miami Community Newspapers. This Miami online group of newspapers
Before birth, all babies have a hole between the two chambers of the heart but when it fails to close naturally after birth it can lead to an increased risk of stroke.
A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99Tc-SPECT myocardial perfusion imaging (MPI), according to research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. 18F-flurpiridaz PET MPI obtained images at a lower radiation dose than 99Tc-SPECT MPI and performed similarly in both obese and non-obese patients.